amgen glp-1 obesity drug market potential What is the pipeline for

However, recent developments indicate a shift in the competitive landscape

GLP-1s: Lower blood sugar Reduce appetiteso you eat less and feel fuller Promote healthy weight loss Improve metabolism Lower whole-body inflammationincluding that which affects your joints GLP-1s Target Both Metabolic and Inflammatory Pathways Recent research shows that GLP-1 medications can: Lower levels of inflammatory cytokines like TNF-alpha, IL-6, and IL-1 Restore a healthier gut microbiome and calm immune reactions Reduce fat-driven inflammationwhy losing just 510% of body weight improves autoimmune diseases Reverse insulin resistancea key link between metabolic and autoimmune disease Reduce oxidative stress, protecting organs and joint cartilage GLP-1s in RA, PsA, OA, and More: Evidence and Results Rheumatoid Arthritis Obesity increases RA risk and severity

Unfortunately, NAFLD is often underdiagnosed because of its asymptomatic nature, the absence of standardized diagnostic assays in everyday clinical practice and the lack of awareness among individuals and physicians (less than 5% of individuals with NAFLD are aware of their disease) [1, 6, 9]

4 Another trial enrolled adults with type 2 diabetes

In society today, there is a similar goal for both men and women: to be smaller and have a snatched waist or a more muscular body